Table of Contents
The Structure of the 2045 Deadline
The quaternary treatment obligation under the recast EU Urban Wastewater Treatment Directive (2024/3019) is not a single date; it is a phased compliance schedule. For utilities serving 150,000 population equivalents or more, Article 8(1) requires:
- By 2033: at least 20% of those plants’ discharges comply with quaternary treatment requirements.
- By 2039: at least 60%.
- By 2045: 100%.
The phasing matters for capex planning. Utilities cannot defer their entire quaternary treatment program to the late 2030s; the 2033 intermediate milestone requires the first tranche of upgrades to be operational within about nine years of the directive’s entry into force in January 2025.
Smaller plants, serving agglomerations of 10,000 to 150,000 population equivalents, face a similar phased schedule (10% by 2033, 30% by 2036, 60% by 2039, 100% by 2045) where they discharge into the risk areas listed under Article 8.
Technology Choice as a Strategic Lever
Quaternary treatment can be delivered through several reference technologies:
- Ozone contactors: proven, well-characterized, effective on a broad range of micropollutants, but demands careful bromate management in bromide-rich waters.
- UV/H2O2 skids: modular, effective on refractory pollutants, but limited by UV transmittance and residual peroxide management.
- PAC adsorbers: effective on hydrophobic micropollutants, but generates PAC-laden sludge requiring disposal.
- Combined trains: ozone plus PAC, or UV/H2O2 plus PAC, are increasingly the reference choice for large plants seeking broad-spectrum removal.
Technology choice depends on influent chemistry, receiving water sensitivity, sludge disposal options, and operating cost tolerance. CEOs should treat this choice as a strategic decision made once, with a 20-30 year operating consequence, rather than as a routine engineering selection.
Funding Structure Under Article 9
Article 9 obliges producers of human medicines and cosmetics to cover at least 80% of the costs of complying with quaternary treatment through extended producer responsibility (EPR) schemes. That funding structure creates both opportunities and challenges for utility CEOs:
- Opportunity: most of the capex burden falls on producers, not on ratepayers.
- Challenge: the utility must document its influent load and treatment efficiency in a way that supports fair EPR invoicing.
- Opportunity: utilities that instrument aggressively can invoice more accurately and reduce disputes with producer contributors.
- Challenge: the allocation methodology is actively contested in 2026. Sixteen legal challenges by pharmaceutical and cosmetics industry associations were dismissed by the EU General Court in February 2026, an appeal is pending before the ECJ, and national proceedings — including an Irish High Court reference to the CJEU in May 2026 — keep the provisions under legal pressure.
CEOs should engage early with their national member state authorities to understand how EPR allocation will be implemented, and how their sensor infrastructure needs to support the allocation methodology.
Sensor Infrastructure as a Strategic Asset
Every quaternary treatment plant funded under this program will carry a substantial sensor package. Typical elements include:
- Multi-parameter sensors on influent, treatment stage, and effluent for compliance-grade measurement.
- In-line pH electrodes on ozone contactors and PAC adsorbers.
- Residual chlorine transmitters configurable for ozone or peroxide service, on the terminal residual monitoring points.
- Online turbidity testers on advanced oxidation feed water.
- Conductivity analyzers for byproduct trending.
- Suspended solids sensors and COD sensors on PAC lines.
Sensor capex is a small share of the total quaternary treatment upgrade cost, but the sensor layer produces the evidence that determines whether the utility can invoice producers for the full 80% EPR share. That bargaining weight makes the sensor layer strategically important out of proportion to its capex share.
Lead Time and Equipment Supply Risk
By 2026, equipment lead times for ozone generators, UV reactors, and modern instrumentation packages are already extending in Europe. Utilities that delay procurement beyond the next two to three years face:
- Ozone generator lead times of 18-30 months for large-capacity units.
- UV reactor lead times of 12-24 months for compliance-grade skids.
- PAC adsorber engineering lead times of 12-18 months.
- Sensor package lead times of 3-6 months, extending to 9-12 months during peak procurement quarters.
CEOs should treat the 2033 milestone as effectively 2030-2031 for capex commitment purposes, allowing for procurement, construction, commissioning, and validation.
Governance and Board Reporting
The quaternary treatment program will show up in utility board reports for the next two decades. Governance structures should include:
- Board-level accountability for the quaternary treatment program, typically vested in the operations or infrastructure committee.
- Annual review of program progress against the 2033, 2039, and 2045 milestones.
- Quarterly review of EPR invoicing performance and disputes.
- Annual review of sensor-based evidence quality and third-party verification results.
- Regular engagement with national member state authorities on methodology and allocation.
Utilities that treat the program as a routine capex line item risk under-investing in governance and losing their negotiating position on EPR invoicing. Utilities that treat it as a strategic program with dedicated governance are positioned to recover more of the 80% cost share.
Financial and Rate Impact
For utilities, the net financial impact of the program depends heavily on:
- The share of quaternary treatment cost successfully recovered through EPR from producers.
- The share left to ratepayers under member state rules.
- The financing structure used for the capex tranche not covered by EPR.
- Operating cost inflation across energy, reagents, and PAC over the program horizon.
Current utility financial models point in one consistent direction: ratepayer impact is materially lower where EPR recovery is strong, and can grow several times larger where EPR recovery is weak or contested.
Roadmap Recommendation for Utility CEOs
CEOs of affected utilities should structure their response into four phases:
- Phase 1 (2026-2027): technology choice, funding structure, and sensor strategy locked in.
- Phase 2 (2027-2032): first tranche of upgrades procured, constructed, and commissioned to meet the 2033 milestone.
- Phase 3 (2033-2038): second tranche of upgrades to meet the 2039 milestone.
- Phase 4 (2038-2045): final tranche and program-wide optimization.
Each phase requires clear milestones, board oversight, EPR engagement, and sensor infrastructure that produces auditable evidence.
What This Means for Executive Teams
The quaternary treatment deadline schedule is one of the defining infrastructure commitments of the European water sector in the current decade. Utility CEOs face binding capex, phased milestones, contested EPR allocation, and a sensor infrastructure requirement that is strategically important out of proportion to its capex share. Shanghai ChiMay’s residual chlorine transmitter, multi-parameter sensor, in-line pH electrode, and online turbidity tester product families give CEOs the drift-managed, digitally integrated measurement stack that supports fair EPR invoicing, credible compliance reporting, and defensible sustainability disclosure across the two-decade horizon of the program.
